Netvax

RSS

Withdrawn

This medicine's authorisation has been withdrawn

adjuvanted vaccine against necrotic enteritis of chickens due to Clostridium perfringens
MedicineVeterinaryWithdrawn

Irish is available via eTranslation, the European Commission's machine translation service.

Translate to Irish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Netvax has been withdrawn at the request of the marketing authorisation holder.

български (BG) (691.18 KB - PDF)

Amharc

español (ES) (513.14 KB - PDF)

Amharc

čeština (CS) (657.18 KB - PDF)

Amharc

dansk (DA) (495.53 KB - PDF)

Amharc

Deutsch (DE) (497.85 KB - PDF)

Amharc

eesti (ET) (511.72 KB - PDF)

Amharc

ελληνικά (EL) (691.94 KB - PDF)

Amharc

français (FR) (496.07 KB - PDF)

Amharc

italiano (IT) (495.88 KB - PDF)

Amharc

latviešu (LV) (665.3 KB - PDF)

Amharc

lietuvių (LT) (632.52 KB - PDF)

Amharc

magyar (HU) (632.48 KB - PDF)

Amharc

Malti (MT) (661.22 KB - PDF)

Amharc

Nederlands (NL) (495.23 KB - PDF)

Amharc

polski (PL) (652.17 KB - PDF)

Amharc

português (PT) (512.51 KB - PDF)

Amharc

română (RO) (610.38 KB - PDF)

Amharc

slovenčina (SK) (656.59 KB - PDF)

Amharc

slovenščina (SL) (646.29 KB - PDF)

Amharc

suomi (FI) (512.09 KB - PDF)

Amharc

svenska (SV) (494.45 KB - PDF)

Amharc

Product information

български (BG) (1.53 MB - PDF)

Amharc

español (ES) (644.06 KB - PDF)

Amharc

čeština (CS) (879.61 KB - PDF)

Amharc

dansk (DA) (638.6 KB - PDF)

Amharc

Deutsch (DE) (643.82 KB - PDF)

Amharc

eesti (ET) (634.66 KB - PDF)

Amharc

ελληνικά (EL) (1014.48 KB - PDF)

Amharc

français (FR) (640.93 KB - PDF)

Amharc

italiano (IT) (636.47 KB - PDF)

Amharc

latviešu (LV) (892.65 KB - PDF)

Amharc

lietuvių (LT) (637.98 KB - PDF)

Amharc

magyar (HU) (865.89 KB - PDF)

Amharc

Malti (MT) (891.49 KB - PDF)

Amharc

Nederlands (NL) (628.55 KB - PDF)

Amharc

polski (PL) (859.67 KB - PDF)

Amharc

português (PT) (636.23 KB - PDF)

Amharc

română (RO) (641.64 KB - PDF)

Amharc

slovenčina (SK) (858.29 KB - PDF)

Amharc

slovenščina (SL) (855.5 KB - PDF)

Amharc

suomi (FI) (633.63 KB - PDF)

Amharc

svenska (SV) (636.09 KB - PDF)

Amharc

Íslenska (IS) (647.66 KB - PDF)

Amharc

norsk (NO) (631.53 KB - PDF)

Amharc
Latest procedure affecting product information:IB/0006
19/09/2013

български (BG) (526.17 KB - PDF)

Amharc

español (ES) (505.35 KB - PDF)

Amharc

čeština (CS) (523.19 KB - PDF)

Amharc

dansk (DA) (509.13 KB - PDF)

Amharc

Deutsch (DE) (519.36 KB - PDF)

Amharc

eesti (ET) (508.5 KB - PDF)

Amharc

ελληνικά (EL) (524.31 KB - PDF)

Amharc

français (FR) (506.38 KB - PDF)

Amharc

italiano (IT) (506.08 KB - PDF)

Amharc

latviešu (LV) (523.1 KB - PDF)

Amharc

lietuvių (LT) (510.11 KB - PDF)

Amharc

magyar (HU) (522.92 KB - PDF)

Amharc

Malti (MT) (537.03 KB - PDF)

Amharc

Nederlands (NL) (509.48 KB - PDF)

Amharc

polski (PL) (524.71 KB - PDF)

Amharc

português (PT) (507.63 KB - PDF)

Amharc

română (RO) (507.21 KB - PDF)

Amharc

slovenčina (SK) (523.3 KB - PDF)

Amharc

slovenščina (SL) (519.18 KB - PDF)

Amharc

suomi (FI) (506.63 KB - PDF)

Amharc

svenska (SV) (510.88 KB - PDF)

Amharc

Íslenska (IS) (503.46 KB - PDF)

Amharc

norsk (NO) (501.02 KB - PDF)

Amharc

Product details

Name of medicine
Netvax
Active substance
Clostridium-perfringens-type-A alpha toxoid
International non-proprietary name (INN) or common name
adjuvanted vaccine against necrotic enteritis of chickens due to Clostridium perfringens
Species
Chicken
Anatomical therapeutic chemical veterinary (ATCvet) code
QI01AB08

Pharmacotherapeutic group

Immunologicals for aves

Therapeutic indication

For the active immunisation of chickens to provide passive immunisation against necrotic enteritis to their progeny, during the laying period.

To reduce mortality and the incidence and severity of lesions caused by Clostridium-perfringens-type-A-induced necrotic enteritis. Efficacy was demonstrated by challenge of chicks approximately three weeks after hatching.

The onset of passive transfer of immunity: 6 weeks following completion of the vaccination procedure.

The duration of passive transfer of immunity: 51 weeks following completion of the vaccination procedure.

Authorisation details

EMA product number
EMEA/V/C/000134
Marketing authorisation holder
Intervet International BV

Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Marketing authorisation issued
16/04/2009
Revision
2

Assessment history

This page was last updated on

Share this page